Screener
Summit Therapeutics SMMT Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $27,549 | $20,292 |
| Accrued liabilities | 44,317 | 32,100 |
| Accrued compensation | 7,073 | 14,925 |
| Operating lease liabilities, current portion | 3,179 | 3,388 |
| Other current liabilities | 1,148 | 2,283 |
| Total current liabilities | 83,266 | 72,988 |
| Non-current liabilities: | ||
| Operating lease liabilities, net of current portion | 16,859 | 17,502 |
Item 1. Financial Statements.
FAQ
- What is Summit Therapeutics's operating lease liabilities (current)?
- Summit Therapeutics (SMMT) reported operating lease liabilities (current) of $3.18M in Q1 2026.
- How has Summit Therapeutics's operating lease liabilities (current) changed year-over-year?
- Summit Therapeutics's operating lease liabilities (current) decreased by 10.3% year-over-year, from $3.54M to $3.18M.
- What is the long-term trend for Summit Therapeutics's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Summit Therapeutics's operating lease liabilities (current) has grown at a 54.1% compound annual growth rate (CAGR), from $390K to $3.39M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Summit Therapeutics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude